Vault-13

Knoll Capital Management, LLC

MIAMI, FL · CIK 1325083 · 13F filing filed 2020-08-14

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$173.2m reported value +62.7% vs Q1 2020
19positions
92.8%in top 10
1 new 2 added 1 reduced 0 sold out vs Q1 2020

Holdings, Q2 2020

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 BIOHAVEN PHARMACTL HLDG CO L COM BHVN BHVN 857,494 $62.1m35.84% 35.84% UnchangedShares held: Q4 2019 857.5k, Q1 2020 857.5k, Q2 2020 857.5k
2 CORBUS PHARMACEUTICALS HLDGS COM CRBP CRBP 5,045,870 $42.3m24.44% 24.44% UnchangedShares held: Q4 2019 5.0m, Q1 2020 5.0m, Q2 2020 5.0m
3 APPLIED THERAPEUTICS INC COM APLT APLT 650,238 $23.0m13.27% 13.27% AddedShares held: Q4 2019 467.1k, Q1 2020 642.1k, Q2 2020 650.2k +8.2k +8,167 1.3%
4 ABEONA THERAPEUTICS INC COM COM 2,859,767 $8.2m4.71% 4.71% UnchangedShares held: Q4 2019 2.9m, Q1 2020 2.9m, Q2 2020 2.9m
5 Orgenesis, Inc. COM COM 1,316,364 $8.0m4.62% 4.62% NewShares held: Q4 2019 0, Q1 2020 0, Q2 2020 1.3m
6 EIGER BIOPHARMACEUTICALS INC COM CLDN CLDN 525,238 $5.1m2.92% 2.92% AddedShares held: Q4 2019 350.2k, Q1 2020 475.2k, Q2 2020 525.2k +50.0k +50,000 10.5%
7 ANAVEX LIFE SCIENCES CORP COM NEW AVXL AVXL 724,205 $3.6m2.09% 2.09% UnchangedShares held: Q4 2019 724.2k, Q1 2020 724.2k, Q2 2020 724.2k
8 EXICURE INC COM XCUR XCUR 1,277,777 $3.1m1.77% 1.77% UnchangedShares held: Q4 2019 1.3m, Q1 2020 1.3m, Q2 2020 1.3m
9 ENTERA BIO LTD SHS ENTX ENTX 1,741,363 $3.0m1.74% 1.74% UnchangedShares held: Q4 2019 1.7m, Q1 2020 1.7m, Q2 2020 1.7m
10 ALDEYRA THERAPEUTICS INC COM ALDX ALDX 569,405 $2.4m1.37% 1.37% UnchangedShares held: Q4 2019 569.4k, Q1 2020 569.4k, Q2 2020 569.4k
11 BLACKSTONE GROUP L P COM UNIT LTD BX BX 40,000 $2.2m1.30% 1.30% ReducedShares held: Q4 2019 153.0k, Q1 2020 80.0k, Q2 2020 40.0k -40.0k -40,000 -50.0%
12 CENTURYLINK INC COM CTL CTL 220,000 $2.2m1.25% 1.25% UnchangedShares held: Q4 2019 220.0k, Q1 2020 220.0k, Q2 2020 220.0k
13 SOLIGENIX INC COM COM 787,830 $1.6m0.91% 0.91% UnchangedShares held: Q4 2019 787.8k, Q1 2020 787.8k, Q2 2020 787.8k
14 MOLECULAR TEMPLATES INC COM COM 113,905 $1.5m0.89% 0.89% UnchangedShares held: Q4 2019 113.9k, Q1 2020 113.9k, Q2 2020 113.9k
15 DOW INC COM DOW DOW 30,000 $1.2m0.71% 0.71% UnchangedShares held: Q4 2019 30.0k, Q1 2020 30.0k, Q2 2020 30.0k
16 CATASYS INC COM PAR COM PAR 43,034 $1.1m0.63% 0.63% UnchangedShares held: Q4 2019 43.0k, Q1 2020 43.0k, Q2 2020 43.0k
17 BIOXCEL THERAPEUTICS INC COM COM 20,000 $1.1m0.62% 0.62% UnchangedShares held: Q4 2019 0, Q1 2020 20.0k, Q2 2020 20.0k
18 CORTEVA INC COM CTVA CTVA 30,000 $811.0k0.47% 0.47% UnchangedShares held: Q4 2019 30.0k, Q1 2020 30.0k, Q2 2020 30.0k
19 DUPONT DE NEMOURS INC COM DWDP DWDP 15,000 $785.0k0.45% 0.45% UnchangedShares held: Q4 2019 15.0k, Q1 2020 15.0k, Q2 2020 15.0k

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
ELICIO THERAPEUTICS INC ELTX · 13G · filed 2026-07-08 ELTX 5.3%≈ $4.7m +0.1 pts 13G 2026-07-08